Soyama Hirotoshi, Kuramitsu Kaori, Kido Masahiro, Komatsu Shohei, Gon Hidetoshi, Fukushima Kenji, Urade Takeshi, So Shinichi, Nanno Yoshihide, Tsugawa Daisuke, Goto Tadahiro, Yanagimoto Hiroaki, Asari Sadaki, Toyama Hirochika, Ajiki Tetsuo, Fukumoto Takumi
Department of Surgery, Division of Hepato-Biliary-Pancreatic Surgery, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan.
Department of Surgery, Division of Hepato-Biliary-Pancreatic Surgery, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan.
Transplant Proc. 2023 Jan-Feb;55(1):184-190. doi: 10.1016/j.transproceed.2022.11.003. Epub 2023 Jan 3.
Bile leakage is a major complication after liver transplantation and remains as a significant source of morbidity and mortality. In 2011, the International Study Group of Liver Surgery (ISGLS) defined bile leakage as a drain/serum bilirubin ratio ≥3. However, to our knowledge there is no literature assessing serum and drain bilirubin concentrations after liver transplantation. The aim of this study was to describe the natural postoperative changes in serum and drain fluid bilirubin concentrations in patients after liver transplantation.
We included 32 patients who underwent liver transplantation at Kobe University Hospital from January 2007 to December 2020. We enrolled 34 living donors who had no complications as the control group.
The recipient serum total/direct bilirubin concentration were higher compared with the donors from postoperative day (POD) 1 to 5 with a statistical difference (P < .05). The recipient drain/serum total bilirubin ratio was lower than donors on POD 3 (0.89 ± 0.07 vs 1.53 ± 0.07: P < .0001), which was also confirmed by the recipient drain/serum direct bilirubin ratio (0.64 ± 0.10 vs 1.18 ± 0.09: P < .0001). On POD 3, the drain fluid volume (647.38 ± 89.47 vs 113.43 ± 86.8 mL: P < .001) and serum total bilirubin concentration (6.73 ± 0.61 vs 1.23 ± 0.60 mg/dL: P < .001) was higher in the recipients than in donors. Categorized in 2 groups, the higher drain fluid volume and bilirubin concentration recipients showed lower drain/serum total bilirubin ratio compared with the other group (P = .03) CONCLUSION: The drain/serum bilirubin ratio in the transplanted patients could be calculated lower compared with the hepatectomy patients because of high drain fluid volume and hyperbilirubinemia. Great care should be taken when assessing the bile leakage in liver transplant recipients using the ISGLS definition.
胆漏是肝移植术后的主要并发症,仍是发病和死亡的重要原因。2011年,国际肝脏外科学组(ISGLS)将胆漏定义为引流液/血清胆红素比值≥3。然而,据我们所知,尚无文献评估肝移植术后血清和引流液胆红素浓度。本研究的目的是描述肝移植患者术后血清和引流液胆红素浓度的自然变化。
我们纳入了2007年1月至2020年12月在神户大学医院接受肝移植的32例患者。我们招募了34例无并发症的活体供体作为对照组。
从术后第1天到第5天,受者血清总胆红素/直接胆红素浓度高于供体,差异有统计学意义(P <.05)。受者引流液/血清总胆红素比值在术后第3天低于供体(0.89±0.07 vs 1.53±0.07:P <.0001),受者引流液/血清直接胆红素比值也证实了这一点(0.64±0.10 vs 1.18±0.09:P <.0001)。术后第3天,受者的引流液量(647.38±89.47 vs 113.43±86.8 mL:P <.001)和血清总胆红素浓度(6.73±0.61 vs 1.23±0.60 mg/dL:P <.001)高于供体。分为两组后,引流液量和胆红素浓度较高的受者与另一组相比,引流液/血清总胆红素比值较低(P = 0.03)。结论:由于引流液量高和高胆红素血症,肝移植患者的引流液/血清胆红素比值可能比肝切除患者计算得更低。使用ISGLS定义评估肝移植受者的胆漏时应格外小心。